Takeda Pharmaceutical Shares Owned By Insiders vs. Current Valuation
| TAK Stock | USD 13.38 0.05 0.38% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.78 | 0.5125 |
|
|
For Takeda Pharmaceutical profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Takeda Pharmaceutical to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Takeda Pharmaceutical Co utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Takeda Pharmaceutical's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Takeda Pharmaceutical Co over time as well as its relative position and ranking within its peers.
Takeda |
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Takeda Pharmaceutical. If investors know Takeda will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Takeda Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.049 | Dividend Share 192 | Earnings Share 0.59 | Revenue Per Share 1.4 K | Quarterly Revenue Growth 0.127 |
The market value of Takeda Pharmaceutical is measured differently than its book value, which is the value of Takeda that is recorded on the company's balance sheet. Investors also form their own opinion of Takeda Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Takeda Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Takeda Pharmaceutical's market value can be influenced by many factors that don't directly affect Takeda Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Takeda Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Takeda Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Takeda Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Takeda Pharmaceutical Current Valuation vs. Shares Owned By Insiders Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Takeda Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Takeda Pharmaceutical value to that of its competitors to determine the firm's financial worth. Takeda Pharmaceutical Co is rated below average in shares owned by insiders category among its peers. It is rated third in current valuation category among its peers reporting about 7,639,095,227,667 of Current Valuation per Shares Owned By Insiders. Comparative valuation analysis is a catch-all technique that is used if you cannot value Takeda Pharmaceutical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Takeda Current Valuation vs. Shares Owned By Insiders
Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
Takeda Pharmaceutical |
| = | 0.01 % |
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Takeda Pharmaceutical |
| = | 68.75 B |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Takeda Current Valuation vs Competition
Takeda Pharmaceutical Co is rated third in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is at this time estimated at about 354.49 Billion. Takeda Pharmaceutical retains roughly 68.75 Billion in current valuation claiming about 19% of equities under Health Care industry.
Takeda Pharmaceutical Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Takeda Pharmaceutical, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Takeda Pharmaceutical will eventually generate negative long term returns. The profitability progress is the general direction of Takeda Pharmaceutical's change in net profit over the period of time. It can combine multiple indicators of Takeda Pharmaceutical, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 2.5 T | 2.6 T | |
| Operating Income | 214.1 B | 225 B | |
| Income Before Tax | 52.8 B | 50.2 B | |
| Total Other Income Expense Net | -161.3 B | -153.2 B | |
| Net Income | 144.1 B | 217.6 B | |
| Income Tax Expense | -91.4 B | -86.8 B | |
| Net Income From Continuing Ops | 144.2 B | 167.4 B | |
| Net Income Applicable To Common Shares | 364.6 B | 382.8 B | |
| Net Interest Income | -140.5 B | -147.5 B | |
| Interest Income | 11.3 B | 10.7 B | |
| Change To Netincome | 24.2 B | 25.4 B | |
| Net Income Per Share | 92.09 | 138.75 | |
| Income Quality | 4.44 | 4.67 | |
| Net Income Per E B T | 2.73 | 2.87 |
Takeda Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Takeda Pharmaceutical. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Takeda Pharmaceutical position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Takeda Pharmaceutical's important profitability drivers and their relationship over time.
Use Takeda Pharmaceutical in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Takeda Pharmaceutical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Takeda Pharmaceutical will appreciate offsetting losses from the drop in the long position's value.Takeda Pharmaceutical Pair Trading
Takeda Pharmaceutical Co Pair Trading Analysis
The ability to find closely correlated positions to Takeda Pharmaceutical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Takeda Pharmaceutical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Takeda Pharmaceutical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Takeda Pharmaceutical Co to buy it.
The correlation of Takeda Pharmaceutical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Takeda Pharmaceutical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Takeda Pharmaceutical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Takeda Pharmaceutical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Takeda Pharmaceutical position
In addition to having Takeda Pharmaceutical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Natural Foods Thematic Idea Now
Natural Foods
Companies producing natural foods including dairy products and different types of meets. The Natural Foods theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Natural Foods Theme or any other thematic opportunities.
| View All Next | Launch |
Check out World Market Map. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
To fully project Takeda Pharmaceutical's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Takeda Pharmaceutical at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Takeda Pharmaceutical's income statement, its balance sheet, and the statement of cash flows.